Sign In
Buy BAYRY
$9.92
+0.0400 (+0.405%)
At Close: Jun 03, 2026
Bayer faces Australian test with judge to decide whether weedkiller caused cancer
11:53pm, Monday, 29'th Jan 2024
An Australian court on Tuesday heard closing arguments in a class action lawsuit alleging that a weedkiller produced by Bayer caused cancer, the first such case in Australia to reach this stage.
Bayer shares slump after court tells firm to pay $2.25 billion over Monsanto weedkiller lawsuit
08:14am, Monday, 29'th Jan 2024
Shares in Bayer fell 5% on Monday after a Philadelphia jury told the German pharmaceutical company to pay $2.25 billion to a man who says he developed cancer due to using its Roundup branded weedkille
Bayer ordered to pay $2.25 billion in latest Roundup trial
05:07pm, Friday, 26'th Jan 2024
Bayer was ordered on Friday to pay $2.25 billion to a Pennsylvania man who said he developed cancer from exposure to the company's Roundup weedkiller, the man's attorneys said.
Bayer downgraded over 'multiple adverse factors' faced in 2024
08:55am, Wednesday, 10'th Jan 2024
Bayer AG (ETR:BAYN, OTC:BAYZF) will find it tough to hit last year's targets and faces multiple adverse factors in 2024, said Stifel as it downgraded the German pharma giant and cut its share price t
Bayer plans US expansion despite blood thinner drug setback
08:15pm, Monday, 08'th Jan 2024
Germany's Bayer will continue its expansion into the U.S. despite its November announcement that its promising blood thinner candidate failed to demonstrate superiority over a competing medicine, the
Bayer (BAYRY) Elinzanetant Meets Goals in Late-Stage Studies
12:47pm, Monday, 08'th Jan 2024
Bayer's (BAYRY) experimental candidate, elinzanetant, for the non-hormonal treatment of moderate to severe vasomotor symptoms, meets primary and secondary goals in phase III studies.
Moderna, Bayer-backed genetic therapies company files for IPO
12:04pm, Monday, 08'th Jan 2024
Metagenomi Technologies, a startup developing treatments for genetic diseases backed by Moderna Therapeutics Inc (NASDAQ:MRNA) and Bayer AG (ETR:BAYN, OTC:BAYZF), filed for a US IPO on Friday. Foun
Bayer's menopausal relief drug succeeds in late-stage trial
02:35am, Monday, 08'th Jan 2024
Bayer said its menopausal relief drug eased hot flashes and improved sleep in two late-stage trials, much-needed good news for the German group's pharmaceuticals unit that is reeling from a recent dev
46 Ideal 2024 Fortune And Barron's DiviDogs
03:02am, Sunday, 07'th Jan 2024
In December 2023 - January 2024, Barron's/Fortune analysts-reporters combined to list three sets of stocks: (1) Top 100 of first-ever Euro Fortune 500; (2) 13 Inflation-Proof 2024 stocks; (3) Barron's
Up To 10% Yields: My Top 10 High Dividend Yield Companies For January 2024
07:15am, Saturday, 06'th Jan 2024
High dividend yield companies are essential components within a well-balanced and diversified dividend portfolio, particularly for those seeking to generate substantial additional income via dividends
Bayer (BAYRY) Loses 28% in 2023: What to Expect in 2024?
12:46pm, Friday, 29'th Dec 2023
Bayer (BAYRY) faced challenges in 2023 as sales declined in the Crop Science division. Pipeline setbacks also weighed on the stock.
MustGrow Biologics gives more detail on Bayer AG collaboration
08:31am, Wednesday, 13'th Dec 2023
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) has disclosed further details about its recently announced collaboration agreement with Bayer AG (ETR:BAYN, OTC:BAYZF) following questions received
MustGrow signs commercial license agreement with Bayer for biocontrol technologies in EMEA region
08:14am, Monday, 11'th Dec 2023
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) has announced a collaboration agreement with Bayer AG (ETR:BAYN, OTC:BAYZF) that focuses on the soil applications of MustGrow's mustard-based biocon
Bayer Isn't Dead
01:21pm, Wednesday, 06'th Dec 2023
Bayer AG's financial results show weakness, primarily due to temporary impact from its crop sciences business. Despite challenges, the company's outlook predicts continued respectable performance. Bay
Bayer ordered to pay $3.5 million in latest Roundup weedkiller trial
07:07pm, Tuesday, 05'th Dec 2023
Bayer was ordered on Tuesday to pay nearly $3.5 million by a Philadelphia jury that found the company's Roundup weedkiller caused a woman's cancer, the company said, the latest in a string of trial lo
